Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, +704

The Lancet

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, +724

The Lancet

GlomerulonephritisActive-controlled Clinical TrialRenal FunctionKidney FailureChronic Kidney Disease +7

Renal Involvement in Primary Antiphospholipid Syndrome

Renato Alberto Sinico, Ilaria Cavazzana, Monica Nuzzo, +4

Clinical Journal of the American Society of Nephrology

Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases

Antonella Radice, Federico Pieruzzi, Barbara Trezzi, +16

Journal of Nephrology

Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects

Giuseppe Conte, Antonio Dal Canton, Massimo Sabbatini, +8

Kidney International

UrologyRenal FunctionHealthy SubjectsDopamine InfusionSodium Homeostasis +7

Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall

Giuseppe D’Amico, Pietro Napodano, Franco Ferrario, +2

Kidney International

Glomerular DiseaseGlomerulonephritisUrologyVasculitisSegmental Necrotizing Lesions +9

In Crescentic IgA Nephropathy, Fractional Excretion of IgG in Combination with Nephron Loss Is the Best Predictor of Progression and Responsiveness to Immunosuppression

Claudio Bazzi, Virginia Rizza, Sara Raimondi, +3

Clinical Journal of the American Society of Nephrology

Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: A pilot study

Claudio Bazzi, Concetta Petrini, Virginia Rizza, +5

American Journal of Kidney Diseases

Glomerular DiseaseRenal OutcomeImmunologyPathologyPilot Study +14

Critical re-evaluation of 41 cases of "idiopathic" crescentic glomerulonephritis.

Franco Ferrario, Tadros Mt, Pietro Napodano, +3

PubMed

Glomerular DiseaseVasculitisRenal PathologyImmunologyPathology +21

The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult

Martina Tedesco, Federica Mescia, Isabella Pisani, +30

Kidney International Reports